相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Follicular lymphoma-associated mutations in vacuolar ATPase ATP6V1B2 activate autophagic flux and mTOR
Fangyang Wang et al.
JOURNAL OF CLINICAL INVESTIGATION (2019)
Structural mechanism for Bruton's tyrosine kinase activation at the cell membrane
Qi Wang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)
Switch-like activation of Bruton's tyrosine kinase by membrane-mediated dimerization
Jean K. Chung et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)
Ibrutinib Therapy Releases Leukemic Surface IgM from Antigen Drive in Chronic Lymphocytic Leukemia Patients
Samantha Drennan et al.
CLINICAL CANCER RESEARCH (2019)
Follicular lymphoma
Antonino Carbone et al.
NATURE REVIEWS DISEASE PRIMERS (2019)
BTKCys481Ser drives ibrutinib resistance via ERK1/2 and protects BTKwild-type MYD88-mutated cells by a paracrine mechanism
Jiaji G. Chen et al.
BLOOD (2018)
Single-agent ibrutinib in relapsed or refractory follicular lymphoma: a phase 2 consortium trial
Nancy L. Bartlett et al.
BLOOD (2018)
Chromatin modifying gene mutations in follicular lymphoma
Michael R. Green
BLOOD (2018)
Distinct patterns of B-cell receptor signaling in non-Hodgkin lymphomas identified by single-cell profiling
June H. Myklebust et al.
BLOOD (2017)
Recurrent somatic mutations affecting B-cell receptor signaling pathway genes in follicular lymphoma
Kilannin Krysiak et al.
BLOOD (2017)
Tonic B-cell receptor signaling in diffuse large B-cell lymphoma
Ondrej Havranek et al.
BLOOD (2017)
Sensitivity to PI3K and AKT inhibitors is mediated by divergent molecular mechanisms in subtypes of DLBCL
Tabea Erdmann et al.
BLOOD (2017)
AKT/PKB Signaling: Navigating the Network
Brendan D. Manning et al.
CELL (2017)
Simultaneous Inhibition of PI3Kδ and PI3Kα Induces ABC-DLBCL Regression by Blocking BCR-Dependent and -Independent Activation of NF-κB and AKT
Juliane Paul et al.
CANCER CELL (2017)
Recurrent mTORC1-activating RRAGC mutations in follicular lymphoma
Jessica Okosun et al.
NATURE GENETICS (2016)
Recurrent Mutations in the MTOR Regulator RRAGC in Follicular Lymphoma
Zhang Xiao Ying et al.
CLINICAL CANCER RESEARCH (2016)
Ibrutinib for previously untreated and relapsed or refractory chronic lymphocytic leukaemia with TP53 aberrations: a phase 2, single-arm trial
Mohammed Z. H. Farooqui et al.
LANCET ONCOLOGY (2015)
Targeting B cell receptor signaling with ibrutinib in diffuse large B cell lymphoma
Wyndham H. Wilson et al.
NATURE MEDICINE (2015)
Ibrutinib in Previously Treated Waldenstrom's Macroglobulinemia
Steven P. Treon et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Targets for Ibrutinib Beyond B Cell Malignancies
A. Berglof et al.
SCANDINAVIAN JOURNAL OF IMMUNOLOGY (2015)
Activating STAT6 mutations in follicular lymphoma
Mehmet Yildiz et al.
BLOOD (2015)
Mutations in linker histone genes HIST1H1 B, C, D, and E; OCT2 (POU2F2); IRF8; and ARID1A underlying the pathogenesis of follicular lymphoma
Hongxiu Li et al.
BLOOD (2014)
Integrated genomic analysis identifies recurrent mutations and evolution patterns driving the initiation and progression of follicular lymphoma
Jessica Okosun et al.
NATURE GENETICS (2014)
PI3Kδ Inhibition by Idelalisib in Patients with Relapsed Indolent Lymphoma
Ajay K. Gopal et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Genetics of Follicular Lymphoma Transformation
Laura Pasqualucci et al.
CELL REPORTS (2014)
EZH2 Is Required for Germinal Center Formation and Somatic EZH2 Mutations Promote Lymphoid Transformation
Wendy Beguelin et al.
CANCER CELL (2013)
Targeting BTK with Ibrutinib in Relapsed or Refractory Mantle-Cell Lymphoma
Michael L. Wang et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Targeting BTK with Ibrutinib in Relapsed Chronic Lymphocytic Leukemia
John C. Byrd et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Follicular lymphoma and the immune system: from pathogenesis to antibody therapy
Freda K. Stevenson et al.
BLOOD (2012)
Pathogenesis of follicular lymphoma
Robert Kridel et al.
JOURNAL OF CLINICAL INVESTIGATION (2012)
A selective inhibitor of EZH2 blocks H3K27 methylation and kills mutant lymphoma cells
Sarah K. Knutson et al.
NATURE CHEMICAL BIOLOGY (2012)
The kinase Btk negatively regulates the production of reactive oxygen species and stimulation-induced apoptosis in human neutrophils
Fumiko Honda et al.
NATURE IMMUNOLOGY (2012)
Inactivating mutations of acetyltransferase genes in B-cell lymphoma
Laura Pasqualucci et al.
NATURE (2011)
Frequent mutation of histone-modifying genes in non-Hodgkin lymphoma
Ryan D. Morin et al.
NATURE (2011)
Chronic active B-cell-receptor signalling in diffuse large B-cell lymphoma
R. Eric Davis et al.
NATURE (2010)
Somatic mutations altering EZH2 (Tyr641) in follicular and diffuse large B-cell lymphomas of germinal-center origin
Ryan D. Morin et al.
NATURE GENETICS (2010)
Cytoprotective effects of IAPs revealed by a small molecule antagonist
Stefanie Galban et al.
BIOCHEMICAL JOURNAL (2009)
Comprehensive analysis of copy number and allele status identifies multiple chromosome defects underlying follicular lymphoma pathogenesis
Charles W. Ross et al.
CLINICAL CANCER RESEARCH (2007)
Prediction of survival in follicular lymphoma based on molecular features of tumor-infiltrating immune cells
SS Dave et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Four tyrosine residues in phospholipase C-γ2, identified as Btk-dependent phosphorylation sites, are required for B cell antigen receptor-coupled calcium signaling
D Watanabe et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Interaction between the Btk PH domain and phosphatidylinositol-3,4,5-trisphosphate directly regulates Btk
K Saito et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
分享论文
